Tampilkan postingan dengan label Massachusetts. Tampilkan semua postingan
Tampilkan postingan dengan label Massachusetts. Tampilkan semua postingan

Selasa, 25 Oktober 2016

Capital (spending) is destiny


Today's Managing Health Care Cost Number is $1 billion


Photo by Roger Crogswell, Sibley Hospital, via Flickr creative commons license

Big health care news in Boston over the last week is that Children's Hospital here has cleared the final hurtle to gain approval for a billion dollar expansion.   Children's has overcome community opposition to bulldozing a beloved community garden, and has gained support from the Public Health Commission despite a finding by the state's Health Policy Commission that the expansion will increase medical costs in Massachusetts.  

Children's has claimed that all new resources will be used to provide care to those residing outside of Massachusetts - and thus any impact of this expansion on total Massachusetts costs will be minimal.   But its current volume is only about 30% out-of-state -making it highly likely that Children's market share will increase from the current 46% to 55% or more.

The Health Policy Commission estimates that Children's operating costs will increase by $130 million annually - someone has to staff the 71 new beds, 4 new operating rooms, and 2 new MRI scanners.   The bond payments on a billion dollar bond paid over 20 years with 3% interest rate would be about $70 million a year - so total "new" costs would be about $200 million a year for 20 years.

How could this not raise costs of health care in Massachusetts?

1.       All incremental costs could be covered by out-of-state insurers.  As the HPC noted, that's highly unlikely.  The cost of care would still go up
2.       Children's could cut spending in other areas.  Their new buildings could be more energy efficient - and better facility design could lead to fewer complications and help lower costs.  But this would mean taking other capacity off line -which is not part of this plan
3.       Children's could displace one of the other two pediatric hospitals in Boston. This could lower the amount paid to that facility - but both MGH Hospital for Children and Tufts Floating Hospital are less expensive on a unit cost basis - so movement of volume to Children's is likely to increase overall cost.


Capital expenses drive future health care costs (and trend).  When hospital campuses are full of construction cranes, health care costs are likely to increase more rapidly over the subsequent years.

This is probably an example of capital expense restrictions (such as "determination of need" regulations)  just don't work in the real world.  One commentary in the  Boston Globe was headlined “Children’s Hospital Expansion Plan is built on old-school Boston politics.”  It's hard for politicians and policymakers to argue against one of the world's greatest hospitals which provides world class care to kids -and is among the largest health care employers in the state.  

On completion, this expansion of Children’s Hospital is highly likely to raise overall medical costs in Massachusetts.

Kamis, 13 Oktober 2016

   Drug coupons increase medical costs

Drug coupons increase medical costs


Today's Managing Health Care Cost Number is $2.7 billion

Coupons are a marketing approach to segmenting customers.  The manufacturer using coupons is able to collect a premium price from those purchasers which are not price sensitive, but doesn’t have to sacrifice the volume from price sensitive customers who would otherwise purchase a cheaper product.  

This is true in the grocery section - brand name groceries cost more than store brands, but consumers who are price sensitive clip coupons to get a price that's at least sometimes even lower than the store brand.  But the brand name food company can continue to command high prices from those who didn't clip coupons.

This is especially true in the pharmaceutical space.  Kesselheim and colleagues estimated that pharma coupons increase total medical costs by about $2.5 billion in the US in 2013.   In today's New England Journal, researchers note that fully half the revenue from name brand noninjectable medications comes from drugs for which manufacturers offer coupons.   This generally raises acquisition costs by 60% - as the coupon decreases member out of pocket spend, but does not decrease insurance company spend.

In recent years, the number of copayment coupons being offered has skyrocketed. We estimate that in 2007, a quarter of noninjectable, brand-name drug revenue derived from drugs with copayment coupons; by 2010, that proportion had more than doubled. The availability of coupons has since become rampant; they now appear even in mainstream magazines. We recently examined how these coupons affect spending for drugs that are facing new competition from a generic bioequivalent.3 We estimate that coupons increase the percentage of prescriptions filled with brand-name formulations by more than 60%. Back-of-the-envelope calculations suggest that, on average, each copayment coupon increased national spending on all drugs by $30 million to $120 million over the 5-year period following generic entry. In our sample, consisting of 85 drugs facing generic competition for the first time between 2007 and 2010, we estimate that spending on the 23 drugs with coupons was $700 million to $2.7 billion higher than it would have been if the coupons had not been issued or had been banned.

Today's article notes that these coupons undermine "value based contracting," and that Medicare, Medicaid, and Massachusetts prohibit drug coupons.  (The article is incorrect; Massachusetts lifted the ban on drug coupons in 2012 after substantial pharmaceutical company lobbying). They also note that high priced providers could use similar approaches to retain volume while continuing to charge above-market rates.

Related posts on this topic: